Although the earliest secretory defect in the development of type 2 diabetes is a drop in the first-phase insulin release, a decreased capacity for maximal insulin release is seen prior to a reduction of basal insulin [16]. The gene discussed is INS; the disease is type 2 diabetes mellitus.